Clinical Trials Sponsored by Antios Therapeutics, Inc
Total 3107 results
-
Emergo Therapeutics, Inc.CompletedInfluenza | Influenza -Like IllnessUnited States
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
Sorrento Therapeutics, Inc.WithdrawnSolid Tumor, Adult | Refractory Cancer | Relapsed Solid Neoplasm
-
Karyopharm Therapeutics IncCompletedSolid TumorUnited States, Denmark, Canada
-
Karyopharm Therapeutics IncTerminated
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
Xalud Therapeutics, Inc.Terminated
-
Karyopharm Therapeutics IncTerminatedSolid Tumors | NHLUnited States, Canada
-
Sorrento Therapeutics, Inc.Completed
-
Sorrento Therapeutics, Inc.TerminatedMetastatic Pancreatic CarcinomaUnited States
-
Sorrento Therapeutics, Inc.Active, not recruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain ChronicUnited States
-
Denali Therapeutics Inc.Active, not recruitingAmyotrophic Lateral SclerosisUnited States, Netherlands
-
Chinook Therapeutics, Inc.CompletedHealthy VolunteerUnited States
-
Galvanize Therapeutics, Inc.Active, not recruitingNon Small Cell Lung CancerHong Kong, Spain, Netherlands
-
Sorrento Therapeutics, Inc.Terminated
-
Checkpoint Therapeutics, Inc.TerminatedMetastatic Non-squamous Non Small Cell Lung CancerPeru, Russian Federation, South Africa, New Zealand, Georgia, Thailand, Brazil, Malaysia
-
Anika Therapeutics, Inc.WithdrawnTennis Elbow | Epicondylitis | Epicondylosis
-
Samus Therapeutics, Inc.TerminatedRecurrent Glioblastoma Multiforme (GBM) | Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma | Grade 3 or 4 Astrocytoma | Glioblastoma SurgeryUnited States
-
Pliant Therapeutics, Inc.TerminatedAcute Respiratory Distress Syndrome | SARS-CoV-2United States
-
Samus Therapeutics, Inc.WithdrawnAccelerated Phase MPN | Blast Phase MPN
-
Gemini Therapeutics, Inc.TerminatedMacular Degeneration | Retinal Degeneration | Neovascular Age-related Macular Degeneration | Retinal DiseaseUnited States
-
Lisata Therapeutics, Inc.CompletedPancreatic Cancer | Pancreatic Ductal AdenocarcinomaAustralia
-
Aldeyra Therapeutics, Inc.CompletedDry Eye SyndromesCanada
-
Medicenna Therapeutics, Inc.CompletedGlioblastoma | Glioblastoma Multiforme | Grade IV Astrocytoma | Grade IV GliomaUnited States
-
Aileron Therapeutics, Inc.TerminatedNon Small Cell Lung Cancer | Small-cell Lung CancerUnited States, Spain, Poland, Italy, Serbia, Bosnia and Herzegovina, Germany
-
Partner Therapeutics, Inc.CompletedDrug Kinetics | Drug Effects on PhysiologyCanada
-
Aldeyra Therapeutics, Inc.Completed
-
Travere Therapeutics, Inc.CompletedHealthy SubjectsUnited Kingdom
-
Virios Therapeutics, Inc.CompletedFibromyalgiaUnited States
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Peloton Therapeutics, Inc.Active, not recruitingA Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)Kidney Cancer | Clear Cell Renal Cell Carcinoma | Glioblastoma | Solid Tumor | Glioblastoma Multiforme | Advanced Solid Tumors | GBM | Solid Tumor, Adult | Solid Carcinoma | Glioblastoma, Adult | ccRCC | RCC, Clear Cell Adenocarcinoma | RCC | Renal Cell Carcinoma, Metastatic | Renal Cell Carcinoma Recurrent | Renal Cell...
-
Edgewise Therapeutics, Inc.CompletedMuscular DystrophiesUnited States
-
DurectTherapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Eirion Therapeutics Inc.CompletedLateral Canthal Lines | Crow's FeetUnited States
-
TG Therapeutics, Inc.TerminatedB-cell Non Hodgkin Lymphoma | Richter's TransformationUnited States
-
Melinta Therapeutics, Inc.CompletedAbscess | Cellulitis | Wound Infection | Systemic InflammationUnited States
-
Carmot Therapeutics, Inc.Active, not recruitingObesity | Type2 DiabetesUnited States, Mexico
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States
-
TG Therapeutics, Inc.TerminatedChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States
-
AN2 Therapeutics, IncCompletedRenal InsufficiencyUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Onconic Therapeutics Inc.Completed
-
Click Therapeutics, Inc.WithdrawnSubstance Use Disorder | Drug Addiction | Tobacco Dependence | Drug Dependence | Nicotine AddictionUnited States
-
Onconic Therapeutics Inc.CompletedAnti-Ulcer AgentsKorea, Republic of
-
Applied Therapeutics, Inc.Active, not recruiting
-
Pipeline Therapeutics, Inc.CompletedSensorineural Hearing LossUnited States
-
Galera Therapeutics, Inc.CompletedRenal ImpairmentUnited States
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Cara Therapeutics, Inc.Approved for marketing
-
Cara Therapeutics, Inc.CompletedUremic PruritusUnited States, Canada, Czechia, Australia, Germany, Hungary, Korea, Republic of, New Zealand, Poland, Taiwan, United Kingdom